Suppr超能文献

[作为花粉症预防措施的IgE介导反应第一阶段的脱敏治疗]

[Desensitization at the first stage of IGE-mediated response as hay fever prophylaxis].

作者信息

Gniazdowska B, Gniazdowski R

机构信息

Poradni Otolaryngologicznej Przyklinicznej Przychodni Alergologicznej AM, Bydgoszczy.

出版信息

Pol Tyg Lek. 1990;45(42-44):869-72.

PMID:2098734
Abstract

The aim of our work was to assess the prophylactic aspects of desensitization at the first stage of IgE-mediated response to grass pollen antigens (GPA). Forty six patients aged 10-45 (Me = 20.45) years (group I) and 50 patients aged 11-45 (Me = 19.17) years (group II) were included in to the study. All of them: 1) suffered from allergic rhinitis due to house dust (HD), feathers (F), weed (W) or tree (T) pollen, 2) had also some other allergic diseases, 3) had positive family history of allergic disorders, 4) had reproducible, strongly positive skin reaction of type I to GPA, but 5) did not show any clinical symptoms of hypersensitivity to GPA. Specific immunotherapy with HD, F, W, and T aqueous extracts was administered to both groups for at least 3 successive years, while parallel desensitization with GPA aqueous extract was carried out in group I, only. The symptoms of grass pollinosis were searcher for and the effects of immunotherapy were evaluated in all the patients over the period of at least 5 successive years after the complete course of vaccines administration. Clinical signs of hypersensitivity to GPA became evident in 6 patients (13.04%) of group I and in 27 patients (54.00%) of group II (p less than 0.001). Thus the desensitization at the first stage of IgE-mediated response to GPA effectively prevented development of the symptomatic hay fever. However, the disease revealed itself in few cases still much later and its course was much milder than in people who were not subjected to such a preventive desensitization.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究的目的是评估在对草花粉抗原(GPA)的IgE介导反应的第一阶段进行脱敏的预防作用。46名年龄在10至45岁(中位数=20.45岁)的患者(第一组)和50名年龄在11至45岁(中位数=19.17岁)的患者(第二组)被纳入研究。他们所有人:1)患有因屋尘(HD)、羽毛(F)、杂草(W)或树木(T)花粉引起的过敏性鼻炎,2)还患有其他一些过敏性疾病,3)有过敏性疾病的阳性家族史,4)对GPA有可重复的、强烈阳性的I型皮肤反应,但5)未表现出对GPA过敏的任何临床症状。两组均用HD、F、W和T水提取物进行特异性免疫治疗,连续至少3年,而仅在第一组中用GPA水提取物进行平行脱敏。在疫苗接种全过程后至少连续5年的时间里,对所有患者寻找草花粉症的症状并评估免疫治疗的效果。第一组6名患者(13.04%)和第二组27名患者(54.00%)出现了对GPA过敏的临床体征(p小于0.001)。因此,在对GPA的IgE介导反应的第一阶段进行脱敏可有效预防有症状的花粉热的发生。然而,该疾病仍在少数病例中在很久以后才显现出来,而且其病程比未接受这种预防性脱敏的人要轻得多。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验